Your portfolio companies are innovating at breakneck speed, but is your compliance infrastructure keeping pace? In this edition of our Inside Litigation series, partner Arthur Luk discusses how AI and emerging technologies...

On September 6, 2019, the SEC announced changes to how it will respond to companies that seek to exclude shareholder proposals from their proxy statements under Exchange Act Rule 14a-8.

On December 10, 2020, the US Department of State's Directorate of Defense Trade Controls (DDTC) announced that it was, for the second time, extending temporary relief measures with...

Enforcement Edge is back for another year of the ABA's White Collar Crime Conference, this time in San Francisco.

Enforcement Edge heads to Miami this week for the ABA's White Collar Crime Conference. And Arnold & Porter's White Collar Defense & Investigations group is on the ground in Miami...

Amy Jeffress, co-chair of the firm's White Collar Defense & Investigations practice, was recently featured in The National Law Journal article "FARA Indictment Shows DOJ's Willing to Use Registration...

In welcome news for financial institutions, on October 25, 2021, the Department of Labor (DOL) announced an extended transition period for compliance with the Investment Advice Exemption (PTE 2020-02).

The latest in a growing number of plastic-related litigations, is an enforcement action brought by the state of California on September 23, 2024 against Exxon Mobil (Exxon)...

Drug pricing is an increasingly complex area that combines business knowledge, the review of difficult and sometimes ambiguous regulations, and the understanding of industry practices.

The number of artificial intelligence- and machine learning-enabled medical devices being used in the healthcare industry is increasing by the month, with the U.S. Food and Drug Administration having already authorized...

In our blog post from May this year, we set out what you need to know about the U.S. Food and Drug Administration (FDA) final rule...

Life Sciences & Healthcare Regulatory partners and former FDA officials Howard Sklamberg and Eva Temkin were featured in FDA Watch's podcast series...

Our Legislative & Public Policy team is pleased to provide the January 2026 edition of Capital Snapshot, which includes a monthly summary of the issues, events, and timelines driving federal policy and political decisions.

On August 9, 2022, President Biden signed the CHIPS and Science Act of 2022 (H.R. 4346) (also known as CHIPS+) into law.

Yesterday, we began our review of the Supreme Court's civil constitutional law cases from 1990 to 2019. Between 2005 and 2019, the Supreme Court decided 64 civil constitutional law cases.

The rule takes effect on March 12, 2025. Interested parties may submit comments on or before October 15, 2024.

Partners Kenneth Chernof and James Herschlein, co-chairs of the firm's Litigation group, were featured as "Litigation Leaders" by The American Lawyer's Litigation Daily. The "Litigation Leaders"

In this episode of Bona Fide Needs, Pub K managing editor Bill Olver is joined by Arnold & Porter False Claims Act Practice (FCA) practice partners Tirzah Lollar and Christian Sheehan...

As generative AI and digital platforms face mounting legal challenges, companies must understand how plaintiffs are adapting traditional product liability theories to target modern technologies. This discussion examines emerging litigation strategies drawn from social media trials and AI lawsuits, exploring how these theories may extend beyond platform developers to enterprise users and service providers.

Ryeco discovered the fraud, performed a forensic investigation, and obtained a coverage denial from Selective Insurance Company.